- Home
- PDEX vs LXRX Comparison
PDEX vs LXRX Comparison
Compare PDEX & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDEX
- LXRX
- Stock Information
- Founded
- PDEX 1978
- LXRX 1995
- Country
- PDEX United States
- LXRX United States
- Employees
- PDEX N/A
- LXRX N/A
- Industry
- PDEX Medical/Dental Instruments
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- PDEX Health Care
- LXRX Health Care
- Exchange
- PDEX Nasdaq
- LXRX Nasdaq
- Market Cap
- PDEX 117.9M
- LXRX 124.4M
- IPO Year
- PDEX N/A
- LXRX 2000
- Fundamental
- Price
- PDEX $51.40
- LXRX $0.46
- Analyst Decision
- PDEX Strong Buy
- LXRX Buy
- Analyst Count
- PDEX 1
- LXRX 4
- Target Price
- PDEX $52.00
- LXRX $3.67
- AVG Volume (30 Days)
- PDEX 41.3K
- LXRX 30.7M
- Earning Date
- PDEX 05-01-2025
- LXRX 03-06-2025
- Dividend Yield
- PDEX N/A
- LXRX N/A
- EPS Growth
- PDEX 128.87
- LXRX N/A
- EPS
- PDEX 1.93
- LXRX N/A
- Revenue
- PDEX $61,004,000.00
- LXRX $31,081,000.00
- Revenue This Year
- PDEX $28.63
- LXRX N/A
- Revenue Next Year
- PDEX $3.09
- LXRX $101.91
- P/E Ratio
- PDEX $26.58
- LXRX N/A
- Revenue Growth
- PDEX 26.45
- LXRX 2481.48
- 52 Week Low
- PDEX $16.84
- LXRX $0.28
- 52 Week High
- PDEX $59.60
- LXRX $2.45
- Technical
- Relative Strength Index (RSI)
- PDEX 67.45
- LXRX 50.39
- Support Level
- PDEX $47.00
- LXRX $0.32
- Resistance Level
- PDEX $52.00
- LXRX $0.71
- Average True Range (ATR)
- PDEX 2.56
- LXRX 0.06
- MACD
- PDEX 0.05
- LXRX 0.03
- Stochastic Oscillator
- PDEX 91.84
- LXRX 36.95
About PDEX Pro-Dex Inc.
Pro-Dex Inc is engaged in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used in the orthopedic, thoracic, and craniomaxillofacial (CMF) markets. The company also designs and manufactures multi-axis motion control systems used in factory automation and scientific research markets. Majority of the company's revenue is derived from designing, developing, and manufacturing surgical devices for the medical device and dental industries.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.